All GLG News Analyses Filed Under: Endocrinology

With all the bad press this drug is on the way out. Now the VA will limit its use as well. Despite what the science is, this drug has no way of surviving. Even though not taken off the market, one will be hard-pressed to use it. Any bad outcome and you have no legal recourse.

Pfizers failure on Exubera were not of safety issues, or complicated device, or even consumer marketing problems.  Their biggest issue that brought failure was the lack of payer coverage.  Almost no payer in the US added Exubera to their formulary or saw any value over injectable insulin...

In spite of GSK's best efforts, I am feeling the vibes, both in myself and in those doctors around me, that damage control is not working.  I just attended a Teleconference with C. Beck the other night, and the moderator soundly trounced Avandia, even allowing for his being paid to speak for Takeda's...

The news published in the www.reuters.com is a good example to safeguard patient's health. The call for restricted use of GlaxoSmithKline Plc's diabetes drug Avandia for existing patients and complete withdrawal as an approved drug is made by The U.S. Department of Veterans Affairs only, therefore,...

This is a big hit for Pfizer - a costly product they licensed due to lack of good pipeline products.   Unfortunatley, I don't think they anticipated the issues surrounding the complexity of inhaled insulin, properly marketed the product, or did enough research on the patient side (ie compliane,...

Another large provider votes thumbs-down on Avandia.Actos remains innocent until proven guilty.

The user-friendly and health care provider comfort aspects of an product with otherwise proven safety and efficacy must be considered when deciding how, when, and in what manner to develop f drug product. Despite the desirability of a non-injectibel insulin, the inhaled route of administration and...

Exubera is the first major product to fail primarily due to Pfizer's inability to convince payors of it's value for money There is now significant additional risk in achieving market access after regulatory approval. Pricing and reimbursement decisions will play an increasingly important role in the...

The United States Veterans Administration is probably the best HMO in the country, provided you are measuring the attainment of good clinical outcomes at reasonable cost.  Believe it or not, the VA, which has the unenviable task of providing healthcare to a relatively sick and historically disenfranchised...

new esa in renal anemia. key market in dialysis treatment